U.S. markets close in 4 hours 10 minutes
  • S&P 500

    4,224.16
    +13.92 (+0.33%)
     
  • Dow 30

    33,462.32
    +152.81 (+0.46%)
     
  • Nasdaq

    12,849.65
    -5.16 (-0.04%)
     
  • Russell 2000

    1,986.73
    +17.48 (+0.89%)
     
  • Crude Oil

    93.45
    +1.52 (+1.65%)
     
  • Gold

    1,806.40
    -7.30 (-0.40%)
     
  • Silver

    20.32
    -0.43 (-2.06%)
     
  • EUR/USD

    1.0341
    +0.0039 (+0.38%)
     
  • 10-Yr Bond

    2.8350
    +0.0490 (+1.76%)
     
  • GBP/USD

    1.2226
    +0.0008 (+0.06%)
     
  • USD/JPY

    132.6220
    -0.2510 (-0.19%)
     
  • BTC-USD

    24,410.34
    +401.55 (+1.67%)
     
  • CMC Crypto 200

    576.64
    +1.89 (+0.33%)
     
  • FTSE 100

    7,465.91
    -41.20 (-0.55%)
     
  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

4 Stocks Looking Higher During Earnings Season

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

By Harry Boxer, TheTechTrader

Here are three health stocks and one technology stock that are at or near key breakout points:

Clovis Oncology, Inc. (NASDAQ: CLVS) popped 90 cents, or more than 10%, to $9.73 on 11.7 million shares Wednesday on no news. The move edged the stock out of a declining wedge pattern it's been in since its December top. A break through moving average resistance near $10.45 and then the recent double-top at $11.15-.25 could lead the stock to $13 next.

3D Systems Corporation (NYSE: DDD) climbed 63 cents, or 5.3%, to $12.34 on 2.9 million shares Wednesday. On Monday, the company announced an expanded relationship with Sanmina to manufacture certain plastic 3D printing platforms. Wednesday's move broke the stock out of a month-long wedge formation, and next resistance for the stock, which has nearly doubled in 5 months, is at $14.25.

Fulgent Genetics, Inc. (NASDAQ: FLGT) jumped $1.52, or 10.9%, to $15.42 on 458,900 shares Wednesday. The move, which came on no news from the genetic testing services company, broke the stock out of a 3-month coil. If it can get through lateral resistance right near here in the $15.50 zone, the near-term target is the $16.50 high from November, with the mid-channel target at $18.50.

Mallinckrodt plc (NYSE: MNK) gained 31 cents, or 6.4%, to $5.14 on 6.1 million shares Wednesday on no news from the specialty pharmaceutical company. The stock, which broke out a base in January and had an orderly pullback from resistance on lower volume, has been picking up in the last two sessions, and looking poised to re-test the highs. Initial target is $7.

See Harry's video chart analysis on these stocks.

No holdings.

Harry Boxer is founder of TheTechTrader.com, a live trading room featuring his stock picks, technical market analysis, and live chart presentations.

Image Sourced from Pixabay

0

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.